This study aimed to assess the role of complement C3, hormone-sensitive lipase (HSL), and peroxisome proliferator-activated receptor gamma (PPARgamma) gene expression in familial combined hyperlipidemia (FCHL). mRNA expression of these 3 determinants of adipose tissue fatty acid (FA) metabolism was quantified in subcutaneous adipose tissue of 41 Finnish FCHL patients and 14 normolipidemic control subjects. No difference in steady-state mRNA expression level of C3, HSL, or PPARgamma mRNA was detected between the FCHL patients and the control subjects. Adipose tissue C3 mRNA expression level correlated with the area under the curve (AUC) for glucose and for insulin in FCHL patients and control subjects. HSL mRNA level was positively correlate...
International audienceHormone-sensitive lipase (HSL) and adipose triglyceride lipase (ATGL) regulate...
OBJECTIVE: Familial combined hyperlipidemia (FCHL) has been associated with abnormalities in fatty ...
Almost 40 years after the first description of familial combined hyperlipidaemia (FCHL) as a discret...
Variants in the PPARgamma gene affect fatty acid and glycerol metabolism in familial combined hyperl...
Cardiovascular Research Institute Maastricht, University of Maastricht, Maastricht, The Netherlands....
Background: Dysfunctional adipose tissue plays an important role in the etiology of the metabolic sy...
Item does not contain fulltextPURPOSE OF REVIEW: This review presents recent basic and clinical deve...
Objective - The genetic background of familial combined hyperlipidemia (FCHL) has not been fully cla...
The central component of the complement system, C3, is associated with obesity, metabolic syndrome a...
Familial combined hyperlipidemia (FCHL) shows many features of the metabolic syndrome. The strong ge...
Coronary heart disease (CHD) is the leading cause of death worldwide. Its prevalence is determined b...
Objectives—The genetic background of familial combined hyperlipidemia (FCHL) is currently unclear. W...
International audienceHormone-sensitive lipase (HSL) and adipose triglyceride lipase (ATGL) regulate...
OBJECTIVE: Familial combined hyperlipidemia (FCHL) has been associated with abnormalities in fatty ...
Almost 40 years after the first description of familial combined hyperlipidaemia (FCHL) as a discret...
Variants in the PPARgamma gene affect fatty acid and glycerol metabolism in familial combined hyperl...
Cardiovascular Research Institute Maastricht, University of Maastricht, Maastricht, The Netherlands....
Background: Dysfunctional adipose tissue plays an important role in the etiology of the metabolic sy...
Item does not contain fulltextPURPOSE OF REVIEW: This review presents recent basic and clinical deve...
Objective - The genetic background of familial combined hyperlipidemia (FCHL) has not been fully cla...
The central component of the complement system, C3, is associated with obesity, metabolic syndrome a...
Familial combined hyperlipidemia (FCHL) shows many features of the metabolic syndrome. The strong ge...
Coronary heart disease (CHD) is the leading cause of death worldwide. Its prevalence is determined b...
Objectives—The genetic background of familial combined hyperlipidemia (FCHL) is currently unclear. W...
International audienceHormone-sensitive lipase (HSL) and adipose triglyceride lipase (ATGL) regulate...
OBJECTIVE: Familial combined hyperlipidemia (FCHL) has been associated with abnormalities in fatty ...
Almost 40 years after the first description of familial combined hyperlipidaemia (FCHL) as a discret...